Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Deficit)

v3.21.2
Condensed Statements of Stockholders' Equity (Deficit) - USD ($)
Total
June 2021 Offering
Common Stock
Common Stock
June 2021 Offering
Additional Paid-In Capital
Additional Paid-In Capital
June 2021 Offering
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ (4,490,016)   $ 8,181   $ 7,685,533   $ (12,183,730)
Beginning balance, Shares at Dec. 31, 2019     8,180,937        
Stock-based compensation expense 139,758       139,758    
Warrant expense/ Issuance of warrants 190,993       190,993    
Issuance of common stock 4,871   $ 1   4,870    
Issuance of common stock, Shares     874        
Net loss (547,440)           (547,440)
Ending balance at Mar. 31, 2020 (4,701,834)   $ 8,182   8,021,154   (12,731,170)
Ending balance, Shares at Mar. 31, 2020     8,181,811        
Beginning balance at Dec. 31, 2019 (4,490,016)   $ 8,181   7,685,533   (12,183,730)
Beginning balance, Shares at Dec. 31, 2019     8,180,937        
Warrant expense/ Issuance of warrants $ 516,923            
Issuance of common stock, stock options exercised, Shares 95,349            
Net loss $ (1,639,908)            
Ending balance at Sep. 30, 2020 (5,125,056)   $ 8,207   8,690,375   (13,823,638)
Ending balance, Shares at Sep. 30, 2020     8,206,706        
Beginning balance at Mar. 31, 2020 (4,701,834)   $ 8,182   8,021,154   (12,731,170)
Beginning balance, Shares at Mar. 31, 2020     8,181,811        
Stock-based compensation expense 139,759       139,759    
Warrant expense/ Issuance of warrants 89,515       89,515    
Conversion of notes 63,800   $ 11   63,789    
Conversion of notes, Shares     11,594        
Net loss (421,869)           (421,869)
Ending balance at Jun. 30, 2020 (4,830,629)   $ 8,193   8,314,217   (13,153,039)
Ending balance, Shares at Jun. 30, 2020     8,193,405        
Stock-based compensation expense 139,758       139,758    
Warrant expense/ Issuance of warrants 236,415       236,415    
Issuance of common stock, cashless warrant exercise (1)   $ 14   (15)    
Issuance of common stock, cashless warrant exercise, Shares     13,301        
Net loss (670,599)           (670,599)
Ending balance at Sep. 30, 2020 (5,125,056)   $ 8,207   8,690,375   (13,823,638)
Ending balance, Shares at Sep. 30, 2020     8,206,706        
Beginning balance at Dec. 31, 2020 $ 9,784,356   $ 10,051   24,805,929   (15,031,624)
Beginning balance, Shares at Dec. 31, 2020 10,050,849   10,050,849        
Stock-based compensation expense $ 591,124       591,124    
Warrant expense/ Issuance of warrants 237,768       237,768    
Issuance of common stock 60,391   $ 9   60,382    
Issuance of common stock, Shares     9,000        
Net loss (2,637,068)           (2,637,068)
Ending balance at Mar. 31, 2021 8,036,571   $ 10,060   25,695,203   (17,668,692)
Ending balance, Shares at Mar. 31, 2021     10,059,849        
Beginning balance at Dec. 31, 2020 $ 9,784,356   $ 10,051   24,805,929   (15,031,624)
Beginning balance, Shares at Dec. 31, 2020 10,050,849   10,050,849        
Warrant expense/ Issuance of warrants $ 658,945            
Net loss (9,744,444)            
Ending balance at Sep. 30, 2021 $ 43,161,479   $ 25,155   67,912,392   (24,776,068)
Ending balance, Shares at Sep. 30, 2021 25,155,198   25,155,198        
Beginning balance at Mar. 31, 2021 $ 8,036,571   $ 10,060   25,695,203   (17,668,692)
Beginning balance, Shares at Mar. 31, 2021     10,059,849        
Stock-based compensation expense 322,483       322,483    
Warrant expense/ Issuance of warrants 239,415       239,415    
Issuance of common stock   $ 41,135,357   $ 15,000   $ 41,120,357  
Issuance of common stock, Shares       15,000,000      
Issuance of common stock, stock options exercised (43,295)   $ 74   (43,369)    
Issuance of common stock, stock options exercised, Shares     73,496        
Net loss (2,636,179)           (2,636,179)
Ending balance at Jun. 30, 2021 47,054,352   $ 25,134   67,334,089   (20,304,871)
Ending balance, Shares at Jun. 30, 2021     25,133,345        
Stock-based compensation expense 352,419       352,419    
Warrant expense/ Issuance of warrants 181,762       181,762    
Issuance of common stock, stock options exercised 44,143   $ 21   44,122    
Issuance of common stock, stock options exercised, Shares     21,853        
Net loss (4,471,197)           (4,471,197)
Ending balance at Sep. 30, 2021 $ 43,161,479   $ 25,155   $ 67,912,392   $ (24,776,068)
Ending balance, Shares at Sep. 30, 2021 25,155,198   25,155,198